Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: A randomized double-blind multicenter study

Urology

Volumn 62, Issue 3, 2003, Pages 537-541

  Bundrick, William ^b   Heron, Sean P ^b   Ray, Paul ^b   Schiff, William M ^b   Tennenberg, Alan M ^b   Wiesinger, Barbara A ^b   Wright, Pamela A ^b   Wu, Shu Chen ^b   Zadeikis, Neringa ^b   Kahn, James B ^a  

^a Ortho McNeil Pharmaceutical Incorporated   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; LEVOFLOXACIN;

ABDOMINAL PAIN; ADULT; ANTIBACTERIAL ACTIVITY; ARTHRALGIA; ARTICLE; BACKACHE; BONE PAIN; CHRONIC PROSTATITIS; CLINICAL FEATURE; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ENTEROCOCCUS FAECALIS; ERADICATION THERAPY; ESCHERICHIA COLI; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; PRIORITY JOURNAL; PROSTATE SECRETION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RHINITIS; SIDE EFFECT; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS MITIS; SYMPTOM; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINE CULTURE; VERTIGO;

EID: 0042233728     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00565-X     Document Type: Article

References (16)

1. Lloyd G.L., Schaeffer A.J. The new age of prostatitis. Curr Infect Dis Reports. 3:2001;534-539.
2. Schaeffer A.J., Landis J.R., Knauss J.S., et al. Demographic and clinical characteristics of men with chronic prostatitis the National Institutes of Health Chronic Prostatitis Cohort Study . J Urol. 168:2002;593-598.
3. National guideline for the management of prostatitis. Sex Transm Infect. 75:(suppl 1):1999;S46-S50.
4. Meares E.M. Jr, Stamey T.A. Bacterial prostatitis and recurrent urinary tract infections. Hoeprich P.D. Infectious Diseases. 1972;467-473 Harper & Row, Hagerstown, Maryland.
5. Nickel J.C., Bruce A.W., Reid G. Pathogenesis, diagnosis, and treatment of the prostatitis syndromes. Krane R.J., Siroky M.B., Fitzpatrick J.M. Clinical Urology. 1994;925-938 JB Lippincott, Philadelphia.
6. Weidner W., Schiefer H.G., Krauss H., et al. Chronic prostatitis a thorough search for etiologically involved microorganisms in 1,461 patients . Infection. 19:(suppl 3):1991;S119-S125.
7. Nickel J.C. New concepts in the pathogenesis and treatment of prostatitis. Curr Opin Urol. 2:1992;37-43.
8. Trovan® (trovafloxacin): summary basis of approval. New York, Pfizer, Inc., 1997.
9. Hindes R, Feldman R, Yang J, et al: The changing spectrum of bacterial isolates associated with symptomatic chronic bacterial prostatitis, 1990-2000 (abstract). Program and Abstracts of the 40th Annual Meeting of Infectious Disease Society of America, October 2-27, 2002, Chicago, Illinois.
10. Shaohua P., Jianhua Y., Xuemei S., et al. An etiological study and investigation of drug susceptibility in chronic bacterial prostatitis. Acta Acad Med Hubei. 17:1996;388-390.
11. Collins M.M., Stafford R.S., O'Leary M.P., et al. How com-mon is prostatitis? A national survey of physician visits. J Urol. 159:1998;1224-1228.
12. Goto T., Makinose S., Ohi Y., et al. Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate. Int J Urol. 5:1998;243-246.
13. Drusano G.L., Preston S.L., Van Guilder M., et al. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrobial Agents Chemother. 44:2000;2046-2051.
14. Schaeffer A.J. Prostatitis US perspective . Int J Antimicrobial Agents. 11:1999;205-211.
15. Nickel J.C., Costerton J.W., McLean R.J.C., et al. Bacterial biofilms influence on the pathogenesis, diagnosis and treatment of urinary tract infections . J Antimicrobial Chemother. 33:(suppl A):1994;31-41.
16. Choong S., Whitfield H. Biofilms and their role in infections in urology. BJU Int. 86:2000;935-941.